Novartis reports positive Phase III trial results for ianalumab in immune thrombocytopenia
Novartis reports positive Phase III results for ianalumab in Sjögren's disease
US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist
Formation Bio licenses IMIDomics' anti-CD226 autoimmune programme
Hemogenyx wins USD120,000 grant to advance scalable CAR-T manufacturing
IGI and AbbVie enter global licensing agreement for ISB 2001
Orsini named KalVista's specialty pharmacy partner for EKTERLY (sebetralstat)
Jacobio's JAB-8263 Phase I/II Clinical Trial IND application receives Chinese regulatory approval
AbbVie agrees to acquire Capstan Therapeutics
Sanofi's riliprubart receives orphan drug designation in Japan for CIDP
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers
Galderma's nemolizumab recommended for NHS funding in England and Wales for atopic dermatitis
Sanofi's rilzabrutinib granted US orphan drug designation for sickle cell disease